Do Antidepressants Raise the Risk of Early Death? The 2017 Study

Facebook ↗WhatsApp ↗

Originally published 2017-11-13.

Antidepressants and Mortality: Limits of an Observational Claim

In September 2017 a team from McMaster University in Canada reported that people taking antidepressants had a 33% higher risk of dying during the studies they reviewed than people who were not taking them. The headline spread quickly, often as "antidepressants kill". The real picture is more careful: the finding was an association drawn from observational studies, it did not show that the drugs caused those deaths, and in people who already had heart disease the extra risk was not significant.

If you take an antidepressant and this worries you, do not stop on your own. Stopping suddenly can cause withdrawal-like symptoms and a return of depression. Talk to your doctor, who can weigh your own situation. This article explains what the study did, what it found, what it could not show, and what larger bodies of evidence say about whether these medicines work.

What the McMaster study did

The paper, "The mortality and myocardial effects of antidepressants are moderated by pre-existing cardiovascular disease: a meta-analysis", was published in the journal Psychotherapy and Psychosomatics in 2017. Its first author was Marta Maslej and its senior researcher was evolutionary psychologist Paul Andrews, both at McMaster University in Hamilton, Ontario.

A meta-analysis pools results from earlier studies. This one combined 16 studies covering roughly 375,000 people. (Some early reports said 17 studies and almost 400,000 people; Medical News Today's report on the paper gives 16 and about 375,000.) The team compared antidepressant users with non-users and looked at two outcomes: death from any cause and new cardiovascular events such as heart attacks and strokes.

Crucially, the researchers split the results by people's heart health. They expected the drugs to behave differently in people who already had cardiovascular disease, because the most common antidepressants have a mild blood-thinning effect that might help, rather than harm, people at risk of clots.

What it found

In the general population, antidepressant users had a 33% higher risk of death (hazard ratio 1.33) and a 14% higher risk of new cardiovascular events (hazard ratio 1.14) than non-users. In people with existing heart disease or diabetes, the increase in risk was not statistically significant.

A 33% higher relative risk sounds alarming, but relative risk is not the same as your personal chance of dying. If a group's baseline risk of death over several years is low, a one-third increase still leaves it low. The study reported relative figures, which is normal for this kind of research, but it is worth keeping in mind when reading headlines.

Andrews was blunt about his reaction. "We are very concerned by these results," he said in the university's announcement, adding that people should understand how the drugs interact with the body before taking them. He also argued in press interviews that physicians should generally be more cautious about prescribing them, which is a personal view rather than a conclusion the data could prove.

The serotonin idea behind the result

The team offered a possible biological explanation. Most widely prescribed antidepressants, such as SSRIs (selective serotonin reuptake inhibitors), work by blocking the reabsorption of serotonin into nerve cells. Serotonin is best known as a brain chemical, but organs including the heart, lungs, kidneys and liver also take it up from the blood. The researchers suggested that blocking that uptake throughout the body could, in theory, disturb how those organs work.

This is a hypothesis. The meta-analysis did not test it directly, and Maslej herself noted how little is known about what these drugs do outside the brain. It is an argument for more research, not a proven mechanism of harm.

Why association is not causation here

All the studies pooled in the analysis were observational: they followed people who happened to be taking antidepressants or not. That design cannot separate the effect of the medicine from the reasons people were taking it. The authors themselves said they could not draw conclusions about causality.

There are several obvious confounders:

  • Depression itself. Depression is linked to higher rates of heart disease, stroke and suicide. People on antidepressants are, on average, more unwell than people who are not.
  • Other health problems. Antidepressants are often prescribed for anxiety, chronic pain, sleep problems and other conditions, some of which carry their own risks.
  • Lifestyle factors. Smoking, alcohol use, inactivity and social isolation are more common in people with depression and are hard to adjust for completely.

To be fair to the authors, they did try to address the first point. According to Medical News Today, the higher death risk remained when they looked only at studies that had measured depression before people started medication, and they found no meaningful difference between SSRIs and older tricyclic drugs. Even so, adjusting for depression does not capture how severe it was, or everything else that differs between people who are and are not prescribed these medicines.

The ScienceDaily summary of the study also quoted University of Toronto psychiatrist Benoit Mulsant, who was involved in the work, with an honest admission of uncertainty: "I prescribe antidepressants even though I do not know if they are more harmful than helpful in the long-term." His point was that better long-term research is needed, not that people should abandon treatment.

Do antidepressants work? What the bigger evidence says

The original version of this story claimed that over 90% of antidepressants do not work and that they double the risk of suicide. Neither figure came from the McMaster study, and neither matches the strongest evidence.

The largest review of effectiveness to date, a network meta-analysis led by Andrea Cipriani of the University of Oxford and published in The Lancet in February 2018, pooled 522 double-blind trials with 116,477 participants. It found that all 21 commonly used antidepressants worked better than placebo for the short-term treatment of acute depression in adults. The benefit ranged from small to moderate, and the data mostly covered about eight weeks of treatment.

That review had limits of its own: 78% of the trials were funded by drug companies, people with bipolar or treatment-resistant depression were excluded, and a similar analysis in children and teenagers found much weaker evidence. Cipriani's own advice was balanced: "Medication should always be considered alongside other options, such as psychological therapies, where these are available."

On suicide risk, regulators in the US and elsewhere require warnings that some antidepressants can increase suicidal thoughts in children, teenagers and young adults, especially in the first weeks of treatment or after a dose change. That is a reason for close follow-up with a doctor, not a blanket statement that the drugs double suicide in everyone.

What this means if you take antidepressants

  • Do not stop suddenly. Coming off antidepressants is usually done gradually with medical guidance.
  • Ask questions. It is reasonable to ask your doctor why a particular drug was chosen, how long you should take it, and whether talking therapies, exercise or other options could help alongside or instead of medication.
  • Mention heart health. If you have heart problems or risk factors, tell your doctor so they can factor that in.
  • Get help fast in a crisis. If you have thoughts of harming yourself, contact emergency services or a crisis line straight away (in the US you can call or text 988).

The fair summary of the 2017 study is that it raised a serious question worth investigating, especially for otherwise healthy people taking antidepressants for long periods. It did not prove that the drugs kill, and it is not a reason to stop treatment without talking to a doctor.

Sources: ScienceDaily (McMaster University), 14 September 2017: Antidepressants linked to increased risk of mortality; The Pharmaceutical Journal, 15 September 2017: Antidepressants linked to increased risk of mortality and new cardiovascular events; Oxford Health NHS Foundation Trust, 21 February 2018: Antidepressants more effective than placebo for acute depression in adults; Medical News Today, 19 September 2017: report on the McMaster meta-analysis. Header image originally via the New York Post.

COMMENTS

BLOGGER: 1
  1. Did you know? If you have severe depression and you don't take anti-depressants you are 100% more likely to die? because that's how suicide works.

    ReplyDelete